Durect Corporation News
Eyeing Business Models and Practices that are Sustainable and Value-Creating in the Biotech and Pharmaceutical SectorsMay 16
Why shares of Pain Therapeutics were slashed in half.
CUPERTINO, Calif., May 10, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing. Pfizer's disclosure is ...
Durect Corporation (Nasdaq:DRRX) has been downgraded by TheStreet Ratings from from a hold to sell.